ZA90904B - Nifedipine-containing pharmaceutical compositions and process for the preparation thereof - Google Patents

Nifedipine-containing pharmaceutical compositions and process for the preparation thereof

Info

Publication number
ZA90904B
ZA90904B ZA90904A ZA90904A ZA90904B ZA 90904 B ZA90904 B ZA 90904B ZA 90904 A ZA90904 A ZA 90904A ZA 90904 A ZA90904 A ZA 90904A ZA 90904 B ZA90904 B ZA 90904B
Authority
ZA
South Africa
Prior art keywords
nifedipine
polyvinylpyrrolidone
amount
preparation
pharmaceutical compositions
Prior art date
Application number
ZA90904A
Other languages
English (en)
Inventor
Alan Rhodes
Rhodes Alan
Original Assignee
Ethical Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ethical Pharma Ltd filed Critical Ethical Pharma Ltd
Publication of ZA90904B publication Critical patent/ZA90904B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
ZA90904A 1989-02-14 1990-02-07 Nifedipine-containing pharmaceutical compositions and process for the preparation thereof ZA90904B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898903328A GB8903328D0 (en) 1989-02-14 1989-02-14 Nifedipine-containing pharmaceutical compositions and process for the preparation thereof

Publications (1)

Publication Number Publication Date
ZA90904B true ZA90904B (en) 1991-06-26

Family

ID=10651674

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA90904A ZA90904B (en) 1989-02-14 1990-02-07 Nifedipine-containing pharmaceutical compositions and process for the preparation thereof

Country Status (17)

Country Link
US (1) US5145683A (OSRAM)
EP (1) EP0385582B1 (OSRAM)
JP (1) JPH07112974B2 (OSRAM)
AT (1) ATE79032T1 (OSRAM)
AU (1) AU626130B2 (OSRAM)
CA (1) CA2008972C (OSRAM)
DE (1) DE69000240T2 (OSRAM)
DK (1) DK0385582T3 (OSRAM)
ES (1) ES2052168T3 (OSRAM)
FI (1) FI95347C (OSRAM)
GB (1) GB8903328D0 (OSRAM)
GR (1) GR3005477T3 (OSRAM)
IE (1) IE64682B1 (OSRAM)
NO (1) NO175925C (OSRAM)
NZ (1) NZ232287A (OSRAM)
PH (1) PH26850A (OSRAM)
ZA (1) ZA90904B (OSRAM)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US5662933A (en) * 1993-09-09 1997-09-02 Edward Mendell Co., Inc. Controlled release formulation (albuterol)
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
ES2168351T3 (es) * 1994-12-29 2002-06-16 Shire Deutschland Gmbh & Co Kg Preparaciones farmaceuticas que contienen nifedipina y procedimiento para su preparacion.
US5871776A (en) * 1995-01-31 1999-02-16 Mehta; Atul M. Controlled-release nifedipine
CN1049114C (zh) * 1995-12-07 2000-02-09 上海华联制药公司 一种制备缓释药物制剂的方法
CA2231195C (en) * 1996-07-08 2003-01-21 Edward Mendell Co., Inc. Sustained release matrix for high-dose insoluble drugs
EP0852141A1 (en) 1996-08-16 1998-07-08 J.B. Chemicals & Pharmaceuticals Ltd. Nifedipine containing pharmaceutical extended release composition and a process for the preparation thereof
IT1284604B1 (it) * 1996-09-27 1998-05-21 Roberto Valducci Composizioni farmaceutiche a rilascio controllato per somministrazione orale contenenti nifedipina come sostanza attiva
US5837379A (en) * 1997-01-31 1998-11-17 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US5922352A (en) * 1997-01-31 1999-07-13 Andrx Pharmaceuticals, Inc. Once daily calcium channel blocker tablet having a delayed release core
IN186245B (OSRAM) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6485748B1 (en) 1997-12-12 2002-11-26 Andrx Pharmaceuticals, Inc. Once daily pharmaceutical tablet having a unitary core
US6168806B1 (en) 1999-03-05 2001-01-02 Fang-Yu Lee Orally administrable nifedipine pellet and process for the preparation thereof
US20040115134A1 (en) * 1999-06-22 2004-06-17 Elan Pharma International Ltd. Novel nifedipine compositions
JP4627825B2 (ja) * 1999-09-27 2011-02-09 三生医薬株式会社 被包粒状物質及びその製造方法
MXPA01005370A (es) * 1999-09-30 2004-05-14 Penwest Pharmaceuticals Co Sistema de matriz de liberacion sostenida para farmacos altamente solubles.
RU2188635C2 (ru) * 1999-10-12 2002-09-10 Открытое акционерное общество "Щелковский витаминный завод" Композиционный состав лекарственного средства - блокатора медленных кальциевых каналов
CA2359945C (en) * 1999-11-12 2011-04-26 Abbott Laboratories Inhibitors of crystallization in a solid dispersion
US7364752B1 (en) 1999-11-12 2008-04-29 Abbott Laboratories Solid dispersion pharamaceutical formulations
DE10026698A1 (de) * 2000-05-30 2001-12-06 Basf Ag Selbstemulgierende Wirkstoffformulierung und Verwendung dieser Formulierung
US20030130297A1 (en) * 2001-07-06 2003-07-10 Endo Pharmaceuticals, Inc. Oral administration of 6-hydroxy-oxymorphone for use as an analgesic
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
US20080181948A1 (en) * 2006-11-15 2008-07-31 Abbott Laboratories Solid pharmaceutical dosage formulations
GB2462022B (en) * 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
RU2629843C1 (ru) * 2016-05-24 2017-09-04 федеральное государственное автономное образовательное учреждение высшего образования Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский университет) Способ получения мази нифедипина (варианты)
CN109172534B (zh) * 2018-10-23 2020-08-07 迪沙药业集团有限公司 一种硝苯地平缓释片剂组合物

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
US4285665A (en) * 1978-05-08 1981-08-25 Johnson, Matthey & Co., Limited Engines
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
DE3424553A1 (de) * 1984-07-04 1986-01-09 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen mit dihydropyridinen und verfahren zu ihrer herstellung
IT1178511B (it) * 1984-09-14 1987-09-09 Pharmatec Spa Procedimento per la preparazione di una forma solida per uso orale a base di nifedipina con rilascio
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa

Also Published As

Publication number Publication date
IE64682B1 (en) 1995-08-23
IE900286L (en) 1990-08-14
GB8903328D0 (en) 1989-04-05
FI95347B (fi) 1995-10-13
DK0385582T3 (da) 1992-09-14
NO175925C (no) 1995-01-04
US5145683A (en) 1992-09-08
DE69000240D1 (de) 1992-09-10
DE69000240T2 (de) 1993-02-11
AU4893790A (en) 1990-08-23
NO900370D0 (no) 1990-01-26
NZ232287A (en) 1992-01-29
EP0385582A1 (en) 1990-09-05
JPH07112974B2 (ja) 1995-12-06
ES2052168T3 (es) 1994-07-01
PH26850A (en) 1992-11-05
CA2008972C (en) 1996-09-03
EP0385582B1 (en) 1992-08-05
CA2008972A1 (en) 1990-08-14
JPH02235815A (ja) 1990-09-18
AU626130B2 (en) 1992-07-23
FI900633A0 (fi) 1990-02-08
ATE79032T1 (de) 1992-08-15
NO175925B (no) 1994-09-26
NO900370L (no) 1990-08-15
GR3005477T3 (OSRAM) 1993-05-24
FI95347C (fi) 1996-01-25

Similar Documents

Publication Publication Date Title
GB8903328D0 (en) Nifedipine-containing pharmaceutical compositions and process for the preparation thereof
NZ221962A (en) Oral pharmaceutical compositions comprising a mixture of ibuprofen and aluminium hydroxide and process for their preparation
IL72089A (en) Solid pharmaceutical tablet composition for oral administration and having slow release properties
CA2125685A1 (en) Powders for inhalation and process for preparing them
IL111400A0 (en) Pharmaceutical compositions containing metroprolol and methods for the preparation thereof
ZA200601285B (en) Pharmaceutical compositions containing drospirenone
CA2151967A1 (en) Magnetic nanocomposite compositions and processes for the preparation and use thereof
HU901380D0 (en) Controlling released coat for long-acting compositions
ATE420630T1 (de) Pulverzubereitungen und verfahren zu ihrer herstellung
AU4297089A (en) Dispersable formulation of diclofenac in free acid form
DK0519950T3 (da) Præparat
AU566228B2 (en) Compressed hydroxybutryic acid polymer retarded release vehicle
DE3474024D1 (en) Contraceptive compositions based on esters of levo-norgestrel
FR2477015B1 (OSRAM)
NZ315632A (en) Process for preparing solid dosage forms of very low-dose drugs comprising admixing 1-3% by weight of carrier particles with a solution of drug in water
CA2079558A1 (en) Water-dispersible complex and a process for the production thereof
IL95058A0 (en) Nitrofurantoin particulates and their preparation